andrea_franza Profile Banner
Andrea Franza, MD Profile
Andrea Franza, MD

@andrea_franza

Followers
206
Following
92
Statuses
344

Born in Como, I am currently a Medical Oncology resident at National Cancer Institute, Milan. Main topics: Rare cancers, nice food, books and some good musicšŸ”„

Milano, Lombardia
Joined April 2012
Don't wanna be here? Send us removal request.
@andrea_franza
Andrea Franza, MD
3 months
RT @pawel_sobczuk: Interesting proposal for new response evaluation criteria in epithelioid hemangioendothelioma presented by Andrea Vanzulā€¦
0
9
0
@andrea_franza
Andrea Franza, MD
3 months
Wrapping up last day of #CTOS2024! Again, so many interesting presentations, a fantastic crew of colleagues/friends and a super sunset to say goodbye to SD. @ctosociety
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
1
6
@andrea_franza
Andrea Franza, MD
3 months
RT @FioreDoc: #CTOS2024 Progression / spontaneous regression in #desmoid on active surveillance may be related to altereted immune profilesā€¦
0
5
0
@andrea_franza
Andrea Franza, MD
3 months
RT @FioreDoc: Milan @IstTumori crew at #CTOS2024 @ChirSarcomi_INT šŸ˜€
Tweet media one
0
12
0
@andrea_franza
Andrea Franza, MD
3 months
RT @alegronchi: Ā¼ Great #retroperitoneal #sarcoma session at @ctosociety today. Lots of data coming from international collaboration to undā€¦
0
10
0
@andrea_franza
Andrea Franza, MD
3 months
Postcards from #CTOS2024 day2: opening ceremony, a great presentation by @radaste for SACRO study and some good talks at poster reception at the end of the day. @ctosociety
Tweet media one
Tweet media two
Tweet media three
0
2
9
@andrea_franza
Andrea Franza, MD
3 months
A great start today for @ctosociety 2024 annual meeting in #SanDiego! @TARPSWG semi-annual meeting brought interesting spots and new perspectives in #retroperitonealsarcoma management
Tweet media one
Tweet media two
Tweet media three
0
1
5
@andrea_franza
Andrea Franza, MD
6 months
RT @schoffski: First engineerd cell therapy approved by FDA for patients with a solid tumor: afamitresgene autoleucel accelerated approvalā€¦
0
7
0
@andrea_franza
Andrea Franza, MD
7 months
RT @DrSarcoma: A giant among us has departed. Prof. Chris D.M.Fletcher passed away peacefully yesterday in Boston. He impacted our entireā€¦
0
15
0
@andrea_franza
Andrea Franza, MD
7 months
War do not stop oncology: a great message and a touching talk today in a special session at #aiomgiovani day 2 šŸ‘šŸ»šŸ‘šŸ»@AIOMtweet @AiomFondazione
Tweet media one
0
2
13
@andrea_franza
Andrea Franza, MD
7 months
Smashing out day 1 of #aiomgiovani annual meeting: so many brilliant presentations in a wonderful location! And of course, sharing it with good old friends @AIOMtweet @AiomFondazione
Tweet media one
Tweet media two
Tweet media three
1
2
15
@andrea_franza
Andrea Franza, MD
10 months
An inspiring talk today by #iantannock at ASCO-AIOM clinical research course: so many critical points raised and new perspectives shared. Grateful to attend this course! @AIOMtweet
Tweet media one
0
0
7
@andrea_franza
Andrea Franza, MD
10 months
RT @AIOMtweet: Seconda edizione dellā€™ASCO-AIOM International Clinical Research Course: come sempre grande partecipazione ed entusiasmo. #ASā€¦
0
18
0
@andrea_franza
Andrea Franza, MD
11 months
So many intriguing sessions today at #ESMOSarcomaAndRareCancers24 day 2 and many friends to share these days with #retroperitonealsarcoma #rarecancerawareness @myESMO
Tweet media one
Tweet media two
Tweet media three
0
1
11
@andrea_franza
Andrea Franza, MD
11 months
RT @pawel_sobczuk: #young oncologists are a key part of rare cancers family! Thanks all for coming to our clinical case discussion! Every hā€¦
0
8
0
@andrea_franza
Andrea Franza, MD
11 months
A great kick-off today in Lugano for #ESMOSarcomaAndRareCancers24! Super-honoured for having my clinical case selected for discussion in the very first young oncologist session, and a big thank to @Robertasanfili and @casali_pg for their strong support. @myESMO
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
2
23
@andrea_franza
Andrea Franza, MD
1 year
Thanks to @FrontOncology for publishing today our report of a very rare disease successfully managed with a well known drug. @IstTumori @Robertasanfili @sandro_pasquali @casali_pg
@FrontOncology
Frontiers - Oncology
1 year
New research: Long-term disease stability with bicalutamide in a man with aggressive angiomyxoma: case report and state of art: Aggressive angiomyxoma (AA) is a rare mesenchymal neoplasm, which is commonly diagnosed in females and located inā€¦ #oncology
0
1
7
@andrea_franza
Andrea Franza, MD
1 year
RT @fedenichetti: Our work is out on ā¦@JAMANetworkOpenā© ā—ļø Is NALIRIFOX better than FOLFIRINOX as 1st line for metastatic #pancsm ā“ āŽsimiā€¦
0
18
0
@andrea_franza
Andrea Franza, MD
1 year
RT @MartaBrumby: Beyond first line in #NSCLC WT: a real pleasure to listen to @GLoRussoMD_PhD talking about future perspectives in this touā€¦
0
3
0
@andrea_franza
Andrea Franza, MD
1 year
A beautiful pic of #INT at #AIOM23 and good luck to @MOcchipintiMD for starting his new course in #aiomgiovani working group. Bravo! šŸŽ‰
Tweet media one
1
3
28